Telomerase activity in non-small cell lung cancer

被引:6
|
作者
Dobija-Kubica, Katarzyna [1 ]
Zalewska-Ziob, Marzena [2 ]
Brulinski, Krzysztof [3 ]
Rogozinski, Pawel [3 ]
Wiczkowski, Andrzej [4 ]
Gawrychowska, Agata [2 ]
Gawrychowski, Jacek [2 ]
机构
[1] John Paul II Beskid Oncol Ctr Bielsko Biala, Bielsko Biala, Poland
[2] Med Univ Silesia, Sch Med, Div Dent, Zabrze, Poland
[3] Hosp Pulmonol & Thorac Surg, Thorac Surg Ward, Bystra Slaska, Poland
[4] Univ Bielsko Biala, Bielsko Biala, Poland
来源
关键词
telomerase; TRAP; lung cancer; survival rate;
D O I
10.5114/kitp.2016.58959
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: High telomerase activity has been detected in the majority of malignant neoplasms including lung cancer. The purpose of the study was to attempt to use telomerase activity as a prognostic factor in patients with non-small cell lung cancer (NSCLC). Material and methods: Telomerase activity was analyzed in 47 tissue specimens taken from patients with NSCLC. The control group consisted of 30 specimens of non-cancerous lung parenchyma. Telomerase activity was measured by means of the telomeric repeat amplification protocol (TRAP). Results: Telomerase activity in the neoplastic tissue was significantly higher than in the lung parenchyma that was free from neoplastic infiltration. There was no significant association between telomerase activity and age, gender, tobacco smoking, histological type of the tumor, or staging (pTNM). No association was found between the level of telomerase activity in NSCLC specimens and the two-year survival rate of patients (p = 0.326). A higher level of telomerase activity in poorly differentiated tumors (G3) as compared to moderately differentiated tumors (G2) was detected (p = 0.008). A positive association was identified between telomerase activity in pulmonary parenchyma free from tumor infiltration and the presence of leukocyte infiltration (p = 0.0001). Conclusions: No association was found between the level of telomerase activity in NSCLC specimens and the two-year survival rate of patients. The study has revealed a positive association between telomerase activity and the grade of differentiation (G) in NSCLC.
引用
收藏
页码:15 / 20
页数:6
相关论文
共 50 条
  • [41] Increased Human Telomerase Reverse Transcriptase (hTERT) mRNA Expression but not Telomerase Activity is Related to Survival in Curatively Resected Non-small Cell Lung Cancer
    Metzger, Ralf
    Vallbohmer, Daniel
    Mueller-Tidow, Carsten
    Higashi, Hiroshi
    Bollschweiler, Elfriede
    Warnecke-Eberz, Ute
    Brabender, Jan
    Baldus, Stephan E.
    Xi, Huan
    Berdel, Wolfgang E.
    Serve, Hubert
    Hoelscher, Arnulf H.
    Schneider, Paul M.
    ANTICANCER RESEARCH, 2009, 29 (04) : 1157 - 1162
  • [42] NON-SMALL CELL LUNG-CANCER
    HASKELL, CM
    HOLMES, EC
    CURRENT PROBLEMS IN CANCER, 1987, 11 (01) : 1 - 53
  • [43] Vinorelbine for non-small cell lung cancer
    Piccirillo, Maria Carmela
    Daniele, Gennaro
    Di Maio, Massimo
    Bryce, Jane
    De Feo, Gianfranco
    Del Giudice, Antonia
    Perrone, Francesco
    Morabito, Alessandro
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (03) : 493 - 510
  • [44] Angiogenesis and non-small cell lung cancer
    Cox, G
    Jones, JL
    Walker, RA
    Steward, WP
    O'Byrne, KJ
    LUNG CANCER, 2000, 27 (02) : 81 - 100
  • [45] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
  • [46] SURGERY FOR NON-SMALL CELL LUNG CANCER
    Vrtik, Marosh
    Alam, Naveed Z.
    CANCER FORUM, 2013, 37 (02) : 150 - 153
  • [47] Screening for non-small cell lung cancer
    Ashton, RW
    Jett, JR
    SEMINARS IN ONCOLOGY, 2005, 32 (03) : 253 - 258
  • [48] Oligoprogression in Non-Small Cell Lung Cancer
    Harada, Daijiro
    Takigawa, Nagio
    CANCERS, 2021, 13 (22)
  • [49] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [50] The lymphadenectomy in non-small cell lung cancer
    Chiappetta, Marco
    VIDEO-ASSISTED THORACIC SURGERY, 2022, 7